The Role of the Primary Care Physician During the Active Treatment Phase

Primary Care - Clinics in Office Practice

Volumn 36, Issue 4, 2009, Pages 685-702

  Smith, George F ^a   Toonen, Timothy R ^b  

^a University of Minnesota Physicians   (United States)

^b Minnesota Oncology   (United States)

Author keywords

Active treatment; Cancer; Chemotherapy; Primary care; Radiation therapy; Treatment

Indexed keywords

ALKYLATING AGENT; ALPHA INTERFERON; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; ANXIOLYTIC AGENT; APREPITANT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CISPLATIN; CITALOPRAM; CYCLOPHOSPHAMIDE; CYTOKINE; DEXAMETHASONE; DOLASETRON MESILATE; GRANISETRON; IFOSFAMIDE; LOPERAMIDE; LORAZEPAM; METOCLOPRAMIDE; NITROSOUREA DERIVATIVE; ONDANSETRON; ORAL CONTRACEPTIVE AGENT; PALONOSETRON; PAROXETINE; PROCHLORPERAZINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RECOMBINANT ERYTHROPOIETIN; UNINDEXED DRUG;

ALTERNATIVE MEDICINE; ANALGESIA; ANEMIA; ANXIETY; ANXIETY DISORDER; AZOOSPERMIA; BEHAVIOR THERAPY; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER THERAPY; CAREGIVER BURDEN; CHEMOTHERAPY INDUCED EMESIS; CHRONIC DISEASE; CLINICAL DECISION MAKING; CLINICAL TRIAL; COMORBIDITY; CONSTIPATION; CONTRACEPTION; DEPRESSION; DIARRHEA; DISTRESS SYNDROME; DRUG DOSE TITRATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG USE; FATIGUE; FERTILITY; FEVER; GENERAL PRACTITIONER; HEART TAMPONADE; HUMAN; HYPERCALCEMIA; HYPERTENSION; HYPOGONADISM; INFECTION; INJECTION SITE IRRITATION; MALIGNANT NEOPLASTIC DISEASE; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; NEUROPATHIC PAIN; NEUTROPENIA; NUTRITION; PAIN ASSESSMENT; PATIENT CARE; PATIENT COUNSELING; PATIENT EDUCATION; PREMATURE OVARIAN FAILURE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SEXUAL DYSFUNCTION; SEXUALITY; SOCIAL SUPPORT; STRESS MANAGEMENT; SYMPTOMATOLOGY; THROMBOCYTOPENIA; TUMOR LYSIS SYNDROME; UNITED STATES; VENOUS THROMBOEMBOLISM; XEROSTOMIA;

CACHEXIA; FAMILY PRACTICE; FATIGUE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; NAUSEA; NEOPLASMS; NEUTROPENIA; PAIN; PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; PRIMARY HEALTH CARE; QUALITY ASSURANCE, HEALTH CARE; REFERRAL AND CONSULTATION; UNITED STATES;

EID: 71549118828     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2009.07.001     Document Type: Review

References (94)

1. Sisler J.J., Brown J.B., and Stewart M. Family physician's roles in cancer care. Can Fam Physician 50 (2004) 889-896
2. Brotzman G.L., and Robertson R.G. Role of the primary care physician after the diagnosis of cancer. Prim Care 25 (1998) 401-406
3. Smith G.F., and Toonen T.R. Primary care of the patient with cancer. Am Fam Physician 75 (2007) 1207-1214
4. Earle C.C., and Neville B.A. Under use of necessary care among cancer survivors. Cancer 101 (2004) 1712-1719
5. Ogle K.S., Swanson G.M., Woods N., et al. Cancer and comorbidity redefining chronic diseases. Cancer 88 (2000) 653-663
6. Hickner J., Kent S., Naragon P., et al. Physician's and patient's views of cancer care by family physicians: a report from the American Academy of family physicians national research network. Fam Med 39 2 (2007) 126-131
7. O'Connell B., Kristjanson L., and Orb A. Models of integrated cancer care: a critique of the literature. Aust Health Rev 23 (2000) 163-178
8. Kendall M., Boyd K., Campbell C., et al. How do people with cancer wish to be cared for in primary care? Serial discussion groups of patients and carers. Fam Pract 23 (2006) 644-650
9. Spiegel W., Zidel T., Maier M., et al. Breaking bad news to cancer patients: survey and analysis. Psychooncology 18 (2008) 179-186
10. Anvik T., Holtedahl K.A., and MIkalsen H. "When patients have cancer, they stop seeing me" - the role of the general practitioner in early follow-up of patients with cancer - a qualitative study. BMC Fam Pract 7 9 (2006) 1-9
11. Jefford M., Baravelli C., Dudgeon P., et al. Tailored chemotherapy information faxed to general practitioners improves confidence in managing adverse effects and satisfaction with shared care: results from a randomized controlled trial. J Clin Oncol 26 (2008) 2272-2277
12. Shepherd H.L., Tattersall M.H., and Butow P.N. Physician-identified factors affecting patient participation in reaching treatment decisions. J Clin Oncol 26 (2008) 1724-1731
13. Zeliadt S.B., Ramsey S.D., Penson D.F., et al. Why do men choose one treatment over another? A review of patient decision making for localized prostate cancer. Cancer 106 (2006) 1865-1874
14. Holmes-Rovner M., Stableford S., Fagerlin A., et al. Evidence-based patient choice: a prostate cancer decision aid in plain language. BMC Med Inform Decis Mak 5 1 (2005) 1-11
15. Waljee J.F., Rogers M.A., and Alderman A.K. Decision aids and breast cancer: do they influence choice for surgery and knowledge of treatment options?. J Clin Oncol 25 9 (2007) 1067-1073
16. Whelan T., Levine M., Willan A., et al. Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trial. JAMA 292 4 (2004) 435-441
17. Whelan T., Sawka C., Levine M., et al. Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer. J Natl Cancer Inst 95 8 (2003) 581-587
18. Leighl N.B., Shepherd F.A., Zawissa D., et al. Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer. Br J Cancer 98 11 (2008) 1769-1773
19. Fagerlin A., Rovenr D., Stableford S., et al. Patient education materials about the treatment of early-stage prostate cancer: a critical review. Ann Intern Med 140 9 (2004) 721-728
20. Patrick D.L., Ferketich S.L., Frame P.S., et al. National Institutes of Health state-of-the-science conference statement: symptom management in cancer: pain, depression and fatigue. J Natl Cancer Inst 95 (2003) 1110-1117
21. Roscoe J.A., Kaufman M.E., Matteson-Rusby S.E., et al. Cancer-related fatigue and sleep disorders. Oncologist 12 Suppl 1 (2007) 35-42
22. National Comprehensive Cancer Network. Distress management. In: Clinical practice guidelines in oncology. Available at:. http://www.nccn.org/professionals/physician_gls/default.asp Accessed September 27, 2008
23. Goudas L.C., Bloch R., Gialeli-Goudas M., et al. The epidemiology of cancer pain. Cancer Invest 23 (2005) 182-190
24. Portenoy K., and Lesage P. Management of cancer pain. Lancet 353 (1999) 1695-1700
25. National Comprehensive Cancer Network. Adult cancer pain v2008. In: Clinical practice guidelines in oncology. Available at:. http://www.nccn.org/professional/physician_gls/default.asp Accessed July 6, 2008
26. Hofman M., Ryan J.L., Figueroa-Moseley C.D., et al. Cancer-related fatigue: the scale of the problem. Oncologist 12 Suppl 1 (2007) 4-10
27. National Comprehensive Cancer Network. Cancer-related fatigue v2008. In: Clinical practice guidelines in oncology. Available at:. http://www.nccn.org/professional/physician_gls/default.asp Accessed July 6, 2008
28. Glaus A., Crow R., and Hammond S. A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Support Care Cancer 4 (1996) 82-96
29. Curt G.A., Breitbart W., Cella D., et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5 (2000) 353-360
30. Mustian K.M., Morrow G.R., Carroll J.K., et al. Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue. Oncologist 12 Suppl 1 (2007) 52-67
31. van't Spijker A., Trijsburg R.W., and Duivenvoorden H.J. Psychological sequelae of cancer diagnosis. Psychosom Med 59 (1997) 280-293
32. Massie M.J. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monographs 32 (2004) 57-71
33. Musselman D.L., Lawson D.H., Gumnick J.F., et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 344 (2001) 961-966
34. Lydiatt W.M., Denman D., McNeilly D.P., et al. A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer. Arch Otolaryngol Head Neck Surg 134 5 (2008) 528-535
35. Miller K., and Massie M.J. Depression and anxiety. Cancer J 12 (2006) 388-397
36. Grunfeld E., Coyle D., Whelan T., et al. Family caregiver burden. CMAJ 170 (2004) 1795-1801
37. Langer S., Abrams J., and Syrjala K. Caregiver and patient marital satisfaction and affect following hematopoietic stem cell transplantation: a prospective, longitudinal investigation. Psychooncology 12 (2003) 239-253
38. Hagedorn M., Buunk B.P., Kuijer R.G., et al. Couples dealing with cancer: role and gender differences regarding psychological distress and quality of life. Psychooncology 9 (2000) 232-242
39. Visser A., Huizinga G.A., van der Graaf W.T., et al. The impact of parental cancer on children and the family: a review of the literature. Cancer Treat Rev 30 (2004) 683-694
40. Doyle C., Kushi L., Byers T., et al. Nutrition and physical activity during and after cancer treatment: an American Cancer Society Guide for informed choices. CA Cancer J Clin 56 (2006) 323-353
41. Tartter P.I., Slater G., Papatestas A.E., et al. Cholesterol, weight, height, Quetelet's index, and colon cancer recurrence. J Surg Oncol 27 (1984) 232-235
42. Meloni G., Proia A., Romano A., et al. Obesity and autologous stem cell transplantation in acute myeloid leukemia. Bone Marrow Transplant 28 (2001) 365-367
43. Loulergue P., Mir O., Alexandre J., et al. Low influenza vaccination rate among patients receiving chemotherapy for cancer. [letter]. Ann Oncol 19 9 (2008) 1658
44. Laurence V., Gbolade B.A., Morgan S.J., et al. Contraception for teenagers and young adults with cancer. Eur J Cancer 40 (2004) 2705-2716
45. Taylor-Brown J., Kilpatrick M., Maunsell E., et al. Partner abandonment of women with breast cancer. Myth or reality?. Cancer Pract 8 (2000) 160-164
46. Hordem J.H., and Street A.F. Communicating about patient sexuality and intimacy after cancer: mismatched expectations and unmet needs. Med J Aust 186 (2007) 224-227
47. Schover L.R. Sexuality after cancer. Hematology Am Soc Hematol Educ Program (2005) 523-527
48. Hordern A., and Street A. Constructions of patient sexuality in cancer and palliative care: the patient and health professional perspectives. Soc Sci Med 64 (2007) 1704-1718
49. Lee S.J., Schover L.R., Partridge A.H., et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24 (2006) 2917-2931
50. Marholm E., and Cohen I. Fertility preservation options for women with malignancies. Obstet Gynecol Surv 62 (2006) 58-71
51. Schover L.R., Brey K., Lichtin A., et al. Knowledge and experience regarding cancer, fertility, and sperm banking in younger male survivors. J Clin Oncol 20 (2002) 1880-1889
52. Schover L.R., Brey K., Lichtin A., et al. Oncologists' attitudes and practices regarding banking sperm before cancer treatment. J Clin Oncol 20 (2002) 1890-1897
53. Partridge A.H., Gelber S., Peppercorn J., et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 22 (2004) 4174-4183
54. Jenns K. Importance of nausea. Cancer Nurs 17 (1994) 488-493
55. Hesketh P.J., Kris M.G., Grunberg S.M., et al. Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol 15 (1997) 103-109
56. Hesketh P.J., and Gandara D.R. Serotonin antagonists: a new class of antiemetic agents. J Natl Cancer Inst 83 (1991) 613-620
57. Koeller J.M., Aapro M.S., Gralla R.J., et al. Antiemetic guidelines: creating a more practical treatment approach. Support Care Cancer 10 7 (2002) 519-522
58. Grunberg S.M., and Koeller J.M. Palonosetron: a unique 5-HT3-receptor antagonist for the prevention of chemotherapy-induced emesis. Expert Opin Pharmacother 4 (2003) 2297-2303
59. Kris M.G., Hesketh P.J., Somerfield M.R., et al. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol 24 (2006) 2932-2947
60. Andrews P.L., Bhandari P., Davey P.T., et al. Are all 5-HT3 receptor antagonists the same?. Eur J Cancer 28A Suppl 1 (1992) 52-56
61. Eisenberg P., Figueroa-Vadillo J., Zamora R., et al. Improved prevention of moderately emetogenic chemotherapy induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron. Cancer 98 (2003) 2473-2482
62. Roila F., Tonato M., Cognetti F., et al. Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol 9 (1991) 675-678
63. Hesketh P.J., Grunberg S.M., Gralla R.J., et al. The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multi-national, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin. J Clin Oncol 21 (2003) 4112-4119
64. de Wit R., Herrstedt J., Rapoport B., et al. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy. Eur J Cancer 40 (2004) 403-410
65. Lanciano R., Sherman D.M., Michalski J., et al. The efficacy and safety of once daily Kytril (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy. Cancer Invest 19 (2001) 732-772
66. Hughes W.T., Armstrong D., Bodey G.P., et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34 (2002) 730-751
67. Bodey G.P., Buckley M., Sathe Y.S., et al. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64 (1966) 328-340
68. Cometta A., Calandra T., Gaya H., et al. Monotherapy with meropenem vs combination therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemther 40 (1996) 1108-1115
69. National Comprehensive Cancer Network. Clinical practice guidelines. cancer-related infections v1. 2005. Available at:. http://www.nccn.org/professional/physicians_gls/PDF/infections.pdf Accessed on-line February 25, 2008
70. Rizzo J.D., Somerfield M.R., Hagerty K.L., et al. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol 26 (2008) 132-149
71. Smith T.J., Khatcheressian J., Lyman G.H., et al. 2006 Update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 24 (2006) 3187-3205
72. Bohlius J., Langensiepen S., Schwarzer G., et al. Erythropoetin for patients with malignant disease. Cochrane Database Syst Rev 3 (2006). Art. No.: CD003407.pub2 Doi:10.1002/14651858.CD003407.pub2
73. Littlewood T.J., Bajetta E., Nortier J.W.R.., Vercammen E., et al. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double blind, placebo-controlled trial. J Clin Oncol 19 (2001) 2865-2874
74. Bennett C.L., Silver S.M., Djulbegovic B., et al. Venous thromoembolism and mortality associated with recombinant erythropoietin and darbepoeitin for the treatment of cancer-associated anemia. JAMA 299 (2008) 914-924
75. Ozer H., Mirtsching B., Rader M., et al. Neutropenic events in community practices reduced by first and subsequent cycle pegfilgrastim use. Oncologist 12 (2007) 484-494
76. Balducci l., Hafez A.H., Charu V., et al. Elderly cancer patients receiving chemotherapy benefit from first-cycle pegfilgrastim. Oncologist 12 (2007) 1416-1424
77. Eldar-Lissai A., Cosler L.E., Culakova E., et al. Economic analysis of prophylactic pegfilgastrim in adult cancer patients receiving chemotherapy. Value Health 11 (2008) 172-179
78. Kwak L.W., Halpern J., Olshen R.A., et al. Prognostic significance of actual dose intensity in non-Hodgkins lymphoma patients: results of a tree-structured survival analysis. J Clin Oncol 8 (1990) 963-977
79. Miles S.S., Muggia A.L., and Sipiro H.M. Colonic histological changes induced by 5-fluorouracil. Gastroenterology 43 (1962) 391
80. Rosenoff S.H. Octreotide LAR resolves severe chemotherapy-induce diarrhea (CID) and allows continuation of full-dose therapy. Eur J Cancer Care 13 (2004) 380-383
81. Pazdur R. Cancer management: a multidisciplinary approach: medical, surgical, radiation oncology. 7th edition (2003), Oncology Group, New York
82. Robertson C., Robertson A.G., Hendry J.H., et al. Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J radiat Oncol Biol Phys 40 (1998) 319-329
83. Innocenti M., Moscatelli G., and Lopez S. Efficacy of gelclair in reducing pain in palliative care patients with oral lesions: preliminary findings from an open pilot study. J Pain Symptom Manage 24 (2002) 456-457
84. Brizel D.M., Wasserman T.H., Henke M., et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 19 (2000) 3339-3345
85. Arbetter K.R., Prakash U.B., Tazelaar H.D., et al. Radiation-induced pneumonitis in the "nonirradiated" lung. Mayo Clin Proc 74 (1999) 27-36
86. Cervantes A., and Chirivella I. Oncological emergencies. Ann Oncol 15 Suppl 4 (2004) iv299-iv306
87. Richardson M.A., Sanders T., Palmer J.L., et al. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18 (2000) 2505-2514
88. DiGianni L.M., Garber J.E., and Winer E.P. Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 20 18 Suppl (2002) 34S-38S
89. Sparreboom A., Cox M.C., Acharya M.R., et al. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 22 (2004) 2489-2503
90. Fellowes D., Barnes K., and Wilkinson S. Aromatherapy and massage for symptom relief in patients with cancer. Cochrane Database Syst Rev 3 (2004) CD002287
91. Ezzo J.M., Richardson M.A., Vickers A., et al. Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev 2 (2006). Art No.:CD002285 Doi:10.1002/14651858.CD002285.pub2
92. Russell N.C., Sumler S., and Beinhorn C.M. Role of massage therapy in cancer care. J Altern Complement Med 14 2 (2008) 209-214
93. Billhult A., Bergbom I., and Stener-Victorin E. Massage relieves nausea in women with breast cancer who are undergoing chemotherapy. J Altern Complement Med 13 1 (2007) 3-57
94. Wilkinson S.M., Love S.B., Westcombe A.M., et al. Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: a multicenter randomized controlled trial. J Clin Oncol 25 (2007) 532-539